Beijing SL Pharmaceutical Co Ltd (002038) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Beijing SL Pharmaceutical Co Ltd (002038) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥66.55 Million ≈ $9.74 Million USD) by net assets (CN¥5.70 Billion ≈ $834.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Beijing SL Pharmaceutical Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Beijing SL Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Beijing SL Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Beijing SL Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Beijing SL Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing SL Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bravura Solutions Ltd AU:BVS	0.471x
PPHE Hotel Group Ltd F:32P	0.024x
Barclays PLC LSE:BARC	0.243x
Annexon Inc NASDAQ:ANNX	-0.229x
Pexip Holding ASA OL:PEXIP	0.196x
WEB Travel Group Ltd AU:WEB	0.020x
Mesnac Co Ltd SHE:002073	0.028x
JOST Werke AG XETRA:JST	0.081x

Annual Cash Flow Conversion Efficiency for Beijing SL Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Beijing SL Pharmaceutical Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Beijing SL Pharmaceutical Co Ltd (002038) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.19 Billion ≈ $759.25 Million	CN¥257.66 Million ≈ $37.70 Million	0.050x	+22.90%
2024-12-31	CN¥5.58 Billion ≈ $816.62 Million	CN¥225.49 Million ≈ $33.00 Million	0.040x	-48.99%
2023-12-31	CN¥5.81 Billion ≈ $850.19 Million	CN¥460.20 Million ≈ $67.34 Million	0.079x	+11.33%
2022-12-31	CN¥5.48 Billion ≈ $801.78 Million	CN¥389.82 Million ≈ $57.04 Million	0.071x	-18.44%
2021-12-31	CN¥5.33 Billion ≈ $779.39 Million	CN¥464.63 Million ≈ $67.99 Million	0.087x	+4.57%
2020-12-31	CN¥4.98 Billion ≈ $729.42 Million	CN¥415.84 Million ≈ $60.85 Million	0.083x	-39.59%
2019-12-31	CN¥4.82 Billion ≈ $705.49 Million	CN¥665.83 Million ≈ $97.43 Million	0.138x	+28.62%
2018-12-31	CN¥4.52 Billion ≈ $661.20 Million	CN¥485.17 Million ≈ $71.00 Million	0.107x	+21.25%
2017-12-31	CN¥4.30 Billion ≈ $629.14 Million	CN¥380.72 Million ≈ $55.71 Million	0.089x	-12.31%
2016-12-31	CN¥3.93 Billion ≈ $575.09 Million	CN¥396.86 Million ≈ $58.07 Million	0.101x	-27.73%
2015-12-31	CN¥3.61 Billion ≈ $528.73 Million	CN¥504.87 Million ≈ $73.88 Million	0.140x	-4.41%
2014-12-31	CN¥3.18 Billion ≈ $465.50 Million	CN¥465.00 Million ≈ $68.04 Million	0.146x	+8.93%
2013-12-31	CN¥2.59 Billion ≈ $378.85 Million	CN¥347.41 Million ≈ $50.84 Million	0.134x	-28.91%
2012-12-31	CN¥2.11 Billion ≈ $308.98 Million	CN¥398.60 Million ≈ $58.33 Million	0.189x	+39.20%
2011-12-31	CN¥1.69 Billion ≈ $246.66 Million	CN¥228.59 Million ≈ $33.45 Million	0.136x	-31.02%
2010-12-31	CN¥1.21 Billion ≈ $177.26 Million	CN¥238.13 Million ≈ $34.85 Million	0.197x	+10.81%
2009-12-31	CN¥983.06 Million ≈ $143.85 Million	CN¥174.41 Million ≈ $25.52 Million	0.177x	-30.38%
2008-12-31	CN¥762.61 Million ≈ $111.59 Million	CN¥194.32 Million ≈ $28.44 Million	0.255x	+59.16%
2007-12-31	CN¥551.93 Million ≈ $80.76 Million	CN¥88.36 Million ≈ $12.93 Million	0.160x	+18.56%
2006-12-31	CN¥426.20 Million ≈ $62.37 Million	CN¥57.55 Million ≈ $8.42 Million	0.135x	+8.78%
2005-12-31	CN¥382.49 Million ≈ $55.97 Million	CN¥47.48 Million ≈ $6.95 Million	0.124x	+43.52%
2004-12-31	CN¥361.45 Million ≈ $52.89 Million	CN¥31.26 Million ≈ $4.57 Million	0.086x	-67.43%
2003-12-31	CN¥115.05 Million ≈ $16.84 Million	CN¥30.55 Million ≈ $4.47 Million	0.266x	--

About Beijing SL Pharmaceutical Co Ltd

SHE:002038 China Drug Manufacturers - Specialty & Generic

Market Cap

$865.92 Million

CN¥5.92 Billion CNY

Market Cap Rank

#9490 Global

#2382 in China

Share Price

CN¥5.76

Change (1 day)

+1.77%

52-Week Range

CN¥5.03 - CN¥8.98

All Time High

CN¥10151.79